Home \ Library - Page 3

Library - Page 3

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The importance of identifying and diagnosing signs of brain damage to arterial hypertension

Authors:
T.M. OSTROUMOVA, O.D. OSTROUMOVA

Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

L.N. Eliseeva, S.V. Kartashova

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

Biochemical and morphometric methods for evaluating cognitive disorders in patients with type 2 diabetes mellitus

Author:

Samoilova Yu.G., Leiman O.P., Tonskoye O.S., Matveeva M.V., Kudlai D.A., Oleinik O.A., Zhukova N.G., Ratkin K.R., Fimushkina N.Yu.

Place of publication:

Cardiovascular therapy and prevention, 2020; 19 (4)

Modern drug therapy of post -infectious asthenia. With renewed strength

Author:
V.N. SHISHKOVA

GBUZ "Center for the Pathology of Neurorebilitation Speech" DZ Moscow, Moscow, Russia

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE" No. 4, 2019

Problems of pharmacotherapy of elderly patients

Author:

Ushkalova E.A.

Place of publication:

Neuronyus issue No. 4 (42) 2018

Cognitive disorders in patients with arterial elderly and senile hypertension

Author:

Sharashkina N.V., Ostapenko V.S., Tkacheva O.N., Runikhina N.K., Kotovskaya Yu.V., Mkhitaryan E.A., Lysenkov S.N.

Place of publication:

Cardiovascular therapy and prevention, 2017; 16 (3)

A new direction in the assessment of adherence to treatment is an emphasis on geriatric syndromes

Author:

Chukaeva I.I., Larina V.N., Karpenko D.G., Larin V.G.

Place of publication:

Cardiovascular therapy and prevention, 2017; 16 (3)

The main pathogenetic mechanisms of the development of the vascular pathology of the brain with atherosclerosis and metabolic syndrome: search for correction routes

Authors:

ANTONOVA K.V., LAGODA O.V., Raskurazhev A.A., TANASHYAN M.M.

Volume 10. No. 2 2016

Correction of pathological conditions caused by insulin-resisted hyperglycemia

Authors:

Solovyova E.Yu.*, Karneev A.N. , Tyutyumova E.A.

*GBOU VPO “Russian National Research Medical University named after N.I. Pirogov ", Moscow, Russia

Journal of Neurology and Psychiatry, 9, 2016

Features of the development of neurological complications in patients with type 2 diabetes and metabolic syndrome: the possibility of correction and prevention

Author:
V.N. SHISHKOVA

GBUZ "Center for the Pathology of Neurorebilitation Speech" DZ Moscow, Moscow, Russia

Place of publication:
THERAPEUTIC ARCHIVE, 1, 2015

The effect of Mexidol on the level of neurogenesis markers in acute cerebrovascular disorders in the experiment

Authors:

A.V. Schulkin, I.V. Chernykh, Yu.V. Abalenikhina, M.V. Gatsanoga, O.A. Andryushin, N.A. Kruzhalov, E.N. Yakusheva

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

S.S. Korsakov Journal of Neurology and Psychiatry
2025, Vol. 125, No. 2, pp. 107–112

Oxidate Stress in the Pathogenesis of Chronic Headache

Fedin A.I.

Neuroprotective therapy with age -related macular degeneration

Authors:
VLASOVA A.S. 1*, PETROV S.A. 1*, 2*, RENZYAK E.V. 1*, 3*

1* West Siberian Institute of Postgraduate Medical Education, Tyumen, Russia;
2* Tyumen Scientific Center of the Siberian Branch of the Russian Academy of Sciences, Tyumen, Russia;
3* Khanty-Mansiysk Autonomous Okrug - Yugra District Clinical Hospital, Khanty-Mansiysk, Russia

Possibilities of neurocytoprotheiation during reperfusion therapy

Authors:
SHCHUKIN I.A. 1*, 2*, KOLTSOV I.A. 1*, 2*, FIDLER M.S. 1*, GLUKHAREVA A.P. 1*

1* Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
2* Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Assessment of the effectiveness of ethylmethylhydroxypyridine of succinate with alcohol withdrawal

Authors:
YAKUSHEVA E.N., SHULKIN A.V., ABALENIKHINA Y.V.

The dynamics of domains of emotional-cognitive and motor disorders in the structure of the PIT syndrome in patients who have undergone acute cerebral failure

Authors:
BELKIN V.A., VASILCHENKO I.E., BELKIN A.A.

« 1 2 3 4 5 … 14 »

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com